Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnólia Nasal Gel in Allergic Rhinitis
NCT04670653Phase 3Withdrawn
- Sponsor
- EMS
- Start
- Aug 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Magnólia in allergic rhinitis (AR), sponsored by EMS. Planned start Aug 2022; status: withdrawn.
02
Drugs
Magnólia
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT04670653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04670653.